PUBLISHED ON: November 19, 2015 | Duration: 16 min, 40 sec
Mayuresh Joshi, fund manager at Angel Broking, said that though the FDA issues are an overhang over the stock, Dr Reddy's Lab is likely to expected to post strong topline growth over the next couple of years.
